Cytochrome P4502C is an EDHF synthase in coronary arteries

被引:787
作者
Fisslthaler, B
Popp, R
Kiss, L
Potente, M
Harder, DR
Fleming, I
Busse, R
机构
[1] Univ Frankfurt Klinikum, Inst Kardiovask Physiol, D-60590 Frankfurt, Germany
[2] Univ Giessen, Zentrum Inneren Med, D-35392 Giessen, Germany
[3] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA
关键词
D O I
10.1038/46816
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase. This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF)(1,2). Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.
引用
收藏
页码:493 / 497
页数:5
相关论文
共 22 条
[1]
CYTOCHROME-P-450 MAY LINK INTRACELLULAR CA2+ STORES WITH PLASMA-MEMBRANE CA2+ INFLUX [J].
ALVAREZ, J ;
MONTERO, M ;
GARCIASANCHO, J .
BIOCHEMICAL JOURNAL, 1991, 274 :193-197
[2]
ALVAREZ J, 1992, J BIOL CHEM, V267, P11789
[3]
DISPLAY OF THE CHARACTERISTICS OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR BY A CYTOCHROME P450-DERIVED ARACHIDONIC-ACID METABOLITE IN THE CORONARY MICROCIRCULATION [J].
BAUERSACHS, J ;
HECKER, M ;
BUSSE, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1548-1553
[4]
Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor [J].
Bauersachs, J ;
Popp, R ;
Hecker, M ;
Sauer, E ;
Fleming, I ;
Busse, R .
CIRCULATION, 1996, 94 (12) :3341-3347
[5]
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[6]
ACETYLCHOLINE RELEASES ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AND EDRF FROM RAT-BLOOD VESSELS [J].
CHEN, G ;
SUZUKI, H ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1165-1174
[7]
K+ is an endothelium-derived hyperpolarizing factor in rat arteries [J].
Edwards, G ;
Dora, KA ;
Gardener, MJ ;
Garland, CJ ;
Weston, AH .
NATURE, 1998, 396 (6708) :269-272
[8]
CYTOCHROME P450-DEPENDENT EFFECTS OF BRADYKININ IN THE RAT-HEART [J].
FULTON, D ;
MAHBOUBI, K ;
MCGIFF, JC ;
QUILLEY, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) :99-102
[9]
CHARACTERIZATION OF HUMAN CYTOCHROME-P450 ENZYMES [J].
GUENGERICH, FP .
FASEB JOURNAL, 1992, 6 (02) :745-748
[10]
CHARACTERIZATION OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AS A CYTOCHROME P450-DERIVED ARACHIDONIC-ACID METABOLITE IN MAMMALS [J].
HECKER, M ;
BARA, AT ;
BAUERSACHS, J ;
BUSSE, R .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 481 (02) :407-414